Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Some skin diseases and their treatments can negatively affect male fertility.

This enzyme helps metabolize fatty acids and isoleucine, and could be key in treating neurological diseases and certain cancers.

A woman with a rare ovarian tumor and hyperparathyroidism improved after surgery, highlighting the need for reporting unusual cases to understand and manage rare diseases.

Hashimoto's thyroiditis can sometimes change to Graves' disease, so patients need careful monitoring.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Melatonin is important for skin health and protection, and can be made by the skin or applied to it.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Topical finasteride may help treat facial hirsutism in women.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.